Taiwan FDA registration 09ba47273d389ee348a43fd6324bca4d
"Vitex" immunoassay group complete parathyroid
TW: “維特司”免疫檢驗試劑組完整副甲狀腺
Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS·Registered May 17, 2011 – May 17, 2026ExpiredRegistration details
- Analysis ID
- 09ba47273d389ee348a43fd6324bca4d
- Customs Code
- DHA00602201202
Company information
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Manufacturer Country
- United Kingdom
- Authorized Representative
- DKSH TAIWAN LTD.
Product details
- Intended Use
- In vitro diagnostics is used to quantitatively test the concentration of intact parathyroid (iPTH) in human serum or plasma (EDTA or heparin). It is required for use with the VITROS Eci/ECiQ Immunodiagnostic Systems (VITROS 5600 Integrated System).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Grade Material (Analysis Material Non-Analysis);; A.1150 Calibrated Products;; A.1545 Paracyathroglands Geki Hypogenealogy
- Import Information
- import
Dates and status
- Registration Date
- May 17, 2011
- Expiry Date
- May 17, 2026
About this record
Access comprehensive regulatory information for "Vitex" immunoassay group complete parathyroid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 09ba47273d389ee348a43fd6324bca4d and manufactured by ORTHO-CLINICAL DIAGNOSTICS. The authorized representative in Taiwan is DKSH TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices